2002
DOI: 10.1016/s0145-2126(01)00187-4
|View full text |Cite
|
Sign up to set email alerts
|

The Brazilian pediatric myelodysplastic cooperative group strategies: are they relevant to improve educational approach and correct diagnosis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 30 publications
1
2
0
Order By: Relevance
“…As expected, the youngest patients were those with JMML, whereas patients with RCC and RAEB were older and in the same age range as the control group. The distribution of the MDS types was similar to that found in a larger survey of Brazilian children with MDS …”
Section: Discussionsupporting
confidence: 82%
“…As expected, the youngest patients were those with JMML, whereas patients with RCC and RAEB were older and in the same age range as the control group. The distribution of the MDS types was similar to that found in a larger survey of Brazilian children with MDS …”
Section: Discussionsupporting
confidence: 82%
“…These cases were grouped according to the French-American-British (FAB) Co-operative Group classification of Bennett et al (1982) as: refractory anemia (RA), 39 patients; refractory anemia with ringed sideroblasts (RARS), 6 patients; refractory anemia with excess blasts (RAEB), 17 patients; refractory anemia with excess blast in transformation (RAEBT), 17 patients; and chronic myelomonocytic leukemia (CMML), 14 patients. The sample was subdivided into 66 adult (mean age 40.9 years range 19 to 78 years) and 27 pediatric (mean age 7.9 years, range 1 to 18) patients (Lopes et al, 2002).…”
Section: Methodsmentioning
confidence: 99%
“…BCH is also a member of the Brazilian Cooperative on Pediatric Mielodysplastic syndromes (MDS), a multiprofessional working group whose objectives are: to provide educational support, to establish epidemiological data and to offer support and orientation for diagnosis and treatment on MDS ( Lopes et al , 2002 ). Since around 30% of MDS patients carry a predisposing condition, including congenital dysmorphic syndromes, a medical genetics specialist is required for the appropriate clinical evaluation.…”
Section: Resultsmentioning
confidence: 99%